1. Home
  2. BLTE vs SAIC Comparison

BLTE vs SAIC Comparison

Compare BLTE & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • SAIC
  • Stock Information
  • Founded
  • BLTE 2018
  • SAIC 1969
  • Country
  • BLTE United States
  • SAIC United States
  • Employees
  • BLTE N/A
  • SAIC N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • SAIC EDP Services
  • Sector
  • BLTE Health Care
  • SAIC Technology
  • Exchange
  • BLTE Nasdaq
  • SAIC Nasdaq
  • Market Cap
  • BLTE 4.1B
  • SAIC 4.8B
  • IPO Year
  • BLTE 2022
  • SAIC N/A
  • Fundamental
  • Price
  • BLTE $124.75
  • SAIC $87.08
  • Analyst Decision
  • BLTE Strong Buy
  • SAIC Hold
  • Analyst Count
  • BLTE 5
  • SAIC 8
  • Target Price
  • BLTE $105.00
  • SAIC $115.13
  • AVG Volume (30 Days)
  • BLTE 96.5K
  • SAIC 506.1K
  • Earning Date
  • BLTE 11-10-2025
  • SAIC 12-04-2025
  • Dividend Yield
  • BLTE N/A
  • SAIC 1.70%
  • EPS Growth
  • BLTE N/A
  • SAIC 49.05
  • EPS
  • BLTE N/A
  • SAIC 8.26
  • Revenue
  • BLTE N/A
  • SAIC $7,460,000,000.00
  • Revenue This Year
  • BLTE N/A
  • SAIC N/A
  • Revenue Next Year
  • BLTE N/A
  • SAIC $1.40
  • P/E Ratio
  • BLTE N/A
  • SAIC $10.56
  • Revenue Growth
  • BLTE N/A
  • SAIC 2.23
  • 52 Week Low
  • BLTE $49.00
  • SAIC $87.03
  • 52 Week High
  • BLTE $125.01
  • SAIC $133.00
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 75.17
  • SAIC 31.08
  • Support Level
  • BLTE $108.75
  • SAIC $89.24
  • Resistance Level
  • BLTE $124.73
  • SAIC $92.21
  • Average True Range (ATR)
  • BLTE 7.56
  • SAIC 2.18
  • MACD
  • BLTE 0.44
  • SAIC -0.16
  • Stochastic Oscillator
  • BLTE 96.99
  • SAIC 6.40

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

Share on Social Networks: